DK1228203T3 - Peptid (VIRIP), som inhiberer en cirkulerende virus i mennesker samt anvendelse deraf - Google Patents

Peptid (VIRIP), som inhiberer en cirkulerende virus i mennesker samt anvendelse deraf

Info

Publication number
DK1228203T3
DK1228203T3 DK00987221T DK00987221T DK1228203T3 DK 1228203 T3 DK1228203 T3 DK 1228203T3 DK 00987221 T DK00987221 T DK 00987221T DK 00987221 T DK00987221 T DK 00987221T DK 1228203 T3 DK1228203 T3 DK 1228203T3
Authority
DK
Denmark
Prior art keywords
virip
virus
peptide
activity
antagonist
Prior art date
Application number
DK00987221T
Other languages
English (en)
Inventor
Frank Kirchhoff
Jan Muench
Ludger Staendker
Wolf-Georg Forssmann
Knut Adermann
Original Assignee
Ipf Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999153732 external-priority patent/DE19953732A1/de
Priority claimed from DE2000123665 external-priority patent/DE10023665A1/de
Application filed by Ipf Pharmaceuticals Gmbh filed Critical Ipf Pharmaceuticals Gmbh
Application granted granted Critical
Publication of DK1228203T3 publication Critical patent/DK1228203T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK00987221T 1999-11-08 2000-11-08 Peptid (VIRIP), som inhiberer en cirkulerende virus i mennesker samt anvendelse deraf DK1228203T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999153732 DE19953732A1 (de) 1999-11-08 1999-11-08 Humanes zirkulierendes Virus inhibierendes Peptid (VIRIP) und seine Verwendung
DE2000123665 DE10023665A1 (de) 2000-05-16 2000-05-16 Humanes zirkulierendes Virus inhibierendes Peptid (VIRIP) und seine Verwendung
PCT/EP2000/011020 WO2001034640A2 (de) 1999-11-08 2000-11-08 Humanes zirkulierendes virus inhibierendes peptid (virip) und seine verwendung

Publications (1)

Publication Number Publication Date
DK1228203T3 true DK1228203T3 (da) 2008-10-20

Family

ID=26005679

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00987221T DK1228203T3 (da) 1999-11-08 2000-11-08 Peptid (VIRIP), som inhiberer en cirkulerende virus i mennesker samt anvendelse deraf

Country Status (13)

Country Link
US (1) US7037896B1 (da)
EP (2) EP1228203B1 (da)
JP (1) JP4813720B2 (da)
AT (1) ATE398674T1 (da)
AU (1) AU2354801A (da)
CA (1) CA2390652C (da)
CY (1) CY1108330T1 (da)
DE (1) DE50015216D1 (da)
DK (1) DK1228203T3 (da)
ES (1) ES2307549T3 (da)
HK (1) HK1124083A1 (da)
PT (1) PT1228203E (da)
WO (1) WO2001034640A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100144630A1 (en) * 1999-03-05 2010-06-10 Leland Shapiro Compositions, methods and uses for inhibition and/or treatment of influenza infection
US20100210528A1 (en) * 1999-03-05 2010-08-19 Leland Shapiro Compositions, methods and uses for inhibition and/or treatment of influenza infection
US7655629B2 (en) 2002-12-19 2010-02-02 Ipf Pharmaceuticals Gmbh Peptides and their use for the treatment of HIV infections
CN100577686C (zh) * 2004-06-18 2010-01-06 Ipf医药有限公司 寡聚肽及其治疗hiv感染的用途
EP2025762A3 (en) 2006-01-17 2009-09-30 Health Research Inc. Heteroduplex tracking assay
CN102507824B (zh) * 2011-11-01 2013-10-09 北京三元基因工程有限公司 聚乙二醇修饰蛋白质的修饰位点分析方法
EP3473650A1 (en) * 2017-10-18 2019-04-24 Universitätsklinikum Jena Antibody for the specific detection of caap47/48 fragments
US20230235022A1 (en) * 2020-01-16 2023-07-27 Case Western Reserve University Neutrophil elastase binding peptides and compositions thereof
EP4232460A1 (en) * 2020-10-22 2023-08-30 The University of Hong Kong Compositions of anti-viral peptides and/or compounds and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1303530C (en) 1983-01-21 1992-06-16 Michael Courtney EXPRESSION VECTORS AND THEIR USE FOR THE PREPARATION OF A PROTEIN HAVING HUMAN .alpha. -ANTITRYPSIN ACTIVITY
US5827662A (en) 1989-06-23 1998-10-27 The Trustees Of The University Of Pennsylvania Methods for detecting genetic mutations resulting in protease inhibitor insufficiencies
JPH06509327A (ja) 1991-04-18 1994-10-20 ザ　ユー　エー　ビー　リサーチ　ファンデーション エラスターゼ抑制のための組成とその方法
US5175253A (en) 1991-04-24 1992-12-29 Washington University Binding peptides
US5972901A (en) * 1994-03-23 1999-10-26 Case Western Reserve University Serpin enzyme complex receptor--mediated gene transfer
AU782051B2 (en) 1996-06-03 2005-06-30 Case Western Reserve University Enhanced delivery via serpin enzyme complex receptor

Also Published As

Publication number Publication date
HK1124083A1 (en) 2009-07-03
CY1108330T1 (el) 2014-02-12
WO2001034640A3 (de) 2001-11-01
EP1228203B1 (de) 2008-06-18
US7037896B1 (en) 2006-05-02
JP4813720B2 (ja) 2011-11-09
JP2003516729A (ja) 2003-05-20
WO2001034640A2 (de) 2001-05-17
EP1959013A1 (de) 2008-08-20
EP1228203A2 (de) 2002-08-07
DE50015216D1 (de) 2008-07-31
ES2307549T3 (es) 2008-12-01
PT1228203E (pt) 2008-09-03
EP1959013B1 (de) 2014-04-23
AU2354801A (en) 2001-06-06
ATE398674T1 (de) 2008-07-15
CA2390652C (en) 2011-03-29
CA2390652A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
HK1124083A1 (en) Human circulating virus inhibitory peptide (vrip) and its use (virip)
Bodenmüller et al. Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humans
EP0665754B1 (en) Antimicrobial peptides
CN101675067B (zh) 肽组合物的修饰以提高稳定性和递送效率
Silverman et al. Specific binding sites for muramyl peptides on murine macrophages.
HUT75058A (en) Amplification of the vitamin b12 uptake system using polymers
EP2476694A3 (en) Peptide vaccines for cancers expressing tumor-associated antigens
JPH01501939A (ja) 免疫抑制ペプチドおよび使用法
WO2000007543A2 (en) Conjugates targeted to the interleukin-2 receptors
Kawasaki et al. Amino acids and peptides. XIV. Laminin related peptides and their inhibitory effect on experimental metastasis formation
Ikin et al. N-methyl-D-aspartate/phencyclidine receptor complex of rat forebrain: purification and biochemical characterization
CN1781933B (zh) 胸腺素α1活性片段环肽类似物及其聚乙二醇化衍生物
US8026207B2 (en) Peptides and compositions for inhibiting fungal growth
Rastogi et al. Augmentation of human natural killer cells by splenopentin analogs
CN1962693A (zh) 长效胸腺素α1的聚乙二醇化修饰物
EP0858808B1 (en) Peptides for use in wound treatment
Kutina et al. Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats
AU667290B2 (en) Peptides that block human immunodeficiency virus infections and methods of use thereof
JP3546231B2 (ja) 新規ペプチド、及び該ペプチドを用いた組成物
BR112021008797A2 (pt) Polipeptídeos para o tratamento de síndromes de estresse, imunorreação e derrame
Birr Synthetic small thymic peptides: an immunoregulatory concept
US7419776B1 (en) Method of reducing pathogen load
IL150045A0 (en) Compositions and methods for detecting stress-inducible proteins
CA2398395A1 (en) Conjugates targeted to target receptors
RU96118282A (ru) Пептиды для ингибирования высвобождения пепсина